MARKER THERAPEUTICS, INC. Equity, Fair Value Adjustment
MARKER THERAPEUTICS, INC. (MRKR) reported Equity, Fair Value Adjustment of $3.16 million for the 9-month period ending 2014-09-30, per its 10-Q filed 2014-11-19.
Discontinued › Notes › Fair Value Measures and Disclosures › Fair Value Disclosures › Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis
us-gaap:EquityFairValueAdjustment · last filed 2014-11-19
- MARKER THERAPEUTICS, INC. equity, fair value adjustment for the quarter ending 2014-09-30 was $10.00K.
| Period end | Equity, Fair Value Adjustment 3 month | Equity, Fair Value Adjustment 6 month | Equity, Fair Value Adjustment 9 month |
|---|---|---|---|
| 2014-09-30 | $10.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-19 | $3.16M 10-Q · filed 2014-11-19 | |
| 2014-06-30 | $3.15M 10-Q · filed 2014-08-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |